Skip to main content
Summary
Profile
Financials
Events
Ownership
Options


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol


Invalid Symbol

Latest News

Jim Cramer: Johnson & Johnson Will Do Well With Actelion
INVESTING
JNJMNTA

Johnson & Johnson Sets Late-Stage Vaccine Trial Next Month

By Rob Lenihan
Aug 20, 2020 3:35 PM EDT
No More Tears for Johnson & Johnson?
INVESTING
JNJMNTA

Could Momenta Deal Give Johnson & Johnson Breakout Momentum?

By Bret Kenwell
Aug 19, 2020 1:05 PM EDT
J&J, Eli Lilly Healthy for Your Portfolio Says Causeway Global Manager
Video
JNJMNTA

Johnson & Johnson Gains Drugmaker Momenta in $6.5B Deal

Aug 19, 2020 9:55 AM EDT
Stocks Open Higher on Positive Earnings from J&J, Coca-Cola
MERGERS AND ACQUISITIONS
JNJMNTA

Johnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 Billion

By M. Corey Goldman
Aug 19, 2020 7:10 AM EDT
Roche CEO Bullish on U.S. Drug Market
INVESTING
MNTA

Momenta Rockets After Analysts Get Bullish on Biopharma's Newest Treatment

By Scott Van Voorhis
Jan 15, 2020 11:08 AM EST

Recommended for You

PRESS RELEASES

NUTEX HEALTH ANNOUNCES THAT ITS CEO HAS BEEN INVITED TO PARTICIPATE IN J.P. MORGAN'S 7TH ANNUAL FOUNDERS FORUM IN NEW YORK CITY

By PR Newswire
PRESS RELEASES

Europe's Tax Free Shopping Gains Strength With Record Recovery Rates

By Business Wire
PRESS RELEASES

PHI Group Cooperates With Vietnam-based Tin Thanh Group To Accelerate Solutions For Climate Change, Energy Security, Sustainable Agriculture And Environmental Protection.

By GlobeNewswire
PRESS RELEASES

Advantest Again Distinguished As World's #1 ATE Supplier And THE BEST Large Supplier Of Chip Making Equipment In Annual Customer Satisfaction Survey

By GlobeNewswire